Back to Search
LOIS SHAWVER, PH.D.
PH.D.
Psychologist
NPI: 1609059013Individual
Specialties, Licenses & Credentials
PsychologistPrimary
Psychologist
Code: 103T00000X
PSY4818(CA)
Research & Publications (14)
HIV-1 transmission and cytokine-induced expression of DC-SIGN in human monocyte-derived macrophages.
PMID 12960240·J Leukoc Biol·2003
8-other
Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples.
PMID 12083836·Virology·2002
4-observational
Application of LC/MS/MS in the quantitation of SU101 and SU0020 uptake by 3T3/PDGFr cells.
PMID 12008150·J Pharm Biomed Anal·2002
7-preclinical
Pharmacokinetics and interspecies scaling of a novel VEGF receptor inhibitor, SU5416.
PMID 11804393·J Pharm Pharmacol·2001
7-preclinical
New paradigms for the treatment of cancer: the role of anti-angiogenesis agents.
PMID 10818676·Adv Cancer Res·2000
6-review
Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts.
PMID 10914743·Clin Cancer Res·2000
7-preclinical
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
PMID 10945623·Cancer Res·2000
7-preclinical
The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
PMID 11156244·Clin Cancer Res·2000
7-preclinical
Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity.
PMID 10702262·J Biol Chem·2000
7-preclinical
Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
PMID 10931950·Proc Natl Acad Sci U S A·2000
7-preclinical
Biotransformation of the anti-angiogenic compound SU5416.
PMID 11095590·Drug Metab Dispos·2000
7-preclinical
Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent.
PMID 10888034·Anticancer Drug Des·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 385 BELLEVUE AVE.
OAKLAND, CA 94610 - Phone
- (510) 763-0622
Quick Facts
- NPI
- 1609059013
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile